The ADMET Study of Sibutramine and Some Derivatives as an Appetite Suppressant

سال انتشار: 1399
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 336

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ICCNRT03_017

تاریخ نمایه سازی: 19 شهریور 1399

چکیده مقاله:

Drug design is a creative process to find new drugs. It contains designing molecules in which are parallel in structure and charge with their target as a biomolecule in the body. Due to economical concerns as one of the valuable factors of drug designing compared with laboratory tests, numerous compounds are checked in software and just are entered into laboratory tests unless the acceptable computational results were obtained. On the other hand, some drugs such as sibutramine have severe adverse effect thus finding safer replacements are valuable. Sibutramine is an effective anti appetite drug that was produced in ۱۹۸۸. It controls weight by reducing appetite. However, due to high adverseeffects such as heart attack and stroke, it was withdrawn from the market in many countries since ۲۰۱۰. Therefore the need to design new drug candidates for sibutramine as safer alternatives is a pioneer. Herein some pharmacological properties of sibutramine derivatives are calculated and the results are investigated.

نویسندگان

Jafar Ghanbari Yekta

Department of Chemistry, College of Science, Takestan Branch, Islamic Azad University, Takestan, Iran

Mahboubeh Taherkhani

Department of Chemistry, College of Science, Takestan Branch, Islamic Azad University, Takestan, Iran

Sahar Dezfooli

Young Researchers and Elite Club, Science and Research Branch Islamic Azad University, Tehran, Iran